Changes in expression and activity of the secretory pathway Ca2+ ATPase 1 (SPCA1) in A7r5 vascular smooth muscle cells, cultured at different glucose concentrations by Lai, P & Michelangeli, Francesco
 
 
University of Birmingham
Changes in expression and activity of the secretory
pathway Ca2+ ATPase 1 (SPCA1) in A7r5 vascular
smooth muscle cells, cultured at different glucose
concentrations
Lai, P; Michelangeli, Francesco
DOI:
10.1042/BSR20090058
Citation for published version (Harvard):
Lai, P & Michelangeli, F 2009, 'Changes in expression and activity of the secretory pathway Ca2+ ATPase 1
(SPCA1) in A7r5 vascular smooth muscle cells, cultured at different glucose concentrations', Bioscience
Reports, vol. 29, pp. 397-404. https://doi.org/10.1042/BSR20090058
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Biosci. Rep. (2009) / 29 / 397–404 (Printed in Great Britain) / doi 10.1042/BSR20090058
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A7r5 vascular smooth muscle cells cultured at
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Synopsis
Diabetes mellitus-related vascular disease is often associated with both a dysregulation of Ca2+ homoeostasis and
enhanced secretory activity in VSMCs (vascular smooth muscle cells). Here, we employ a commonly used rat cell line
for VSMCs (A7r5 cells) to investigate the effects of glucose on the expression and activity of the SPCA1 (secretory
pathway Ca2+-ATPase 1; also known as ATP2C1), which is a P-type Ca2+ pump located in the Golgi apparatus that
plays a key role in the secretory pathway. Our results show that mRNA expression levels of SPCA1 are significantly
increased in A7r5 cells cultured in high glucose (25.0 mM)-supplemented medium compared with normal glucose
(5.55 mM)-supplemented medium. SPCA1 protein expression levels and thapsigargin-insensitive Ca2+-dependent
ATPase activity were also consistent with a higher than normal expression level of SPCA1 in high-glucose-cultured
A7r5 cells. Analysis of AVP (arginine-vasopressin)-induced cytosolic Ca2+ transients in A7r5 cells (after pre-treatment
with thapsigargin) showed faster rise and decay phases in cells grown in high glucose medium compared with cells
grown in normal glucose medium, supporting the observation of increased SPCA expression/activity. The significant
levels of both Ca2+-ATPase activity and AVP-induced Ca2+ transients, in the presence of thapsigargin, indicate that
SPCA must play a significant role in Ca2+ uptake within VSMCs. We therefore propose that, if such increases in SPCA
expression and activity also occur in primary VSMCs, this may play a substantial role in the aetiology of diabetes
mellitus-associated vascular disease, due to alterations in Ca2+ homoeostasis within the Golgi apparatus.
Key words: calcium homoeostasis, diabetes, Golgi apparatus, sarcoplasmic/endoplasmic reticulum Ca2+-ATPase
(SERCA), secretory pathway Ca2+-ATPase 1 (SPCA1), vascular smooth muscle cell
INTRODUCTION
Cardiovascular diseases, including those associated with diabetes
mellitus, have long been associated with the dysregulation of
Ca2+ homoeostasis in vascular cells [1]. Comparisons between
healthy and diabetic subjects in the past have shown that the dis-
tribution and use of Ca2+ ions differ between the two conditions.
For example, diabetes has been associated with higher than nor-
mal basal [Ca2+]i in rat-derived cardiac myocytes [2] and VSMCs
(vascular smooth-muscle cells) [3], as demonstrated from their
culture in high-glucose medium. Altered hormone-induced Ca2+
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations used: AVP, arginine-vasopressin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HBSS, Hanks balanced salt solution; HG, high glucose (25 mM) culture medium;
HRP, horseradish peroxidase; NG, normal glucose (5.55 mM) culture medium; RPL19, ribosomal protein L19; SERCA, sarcoplasmic/endoplasmic reticulum Ca2+ -ATPase; SPCA,
secretory pathway Ca2+ -ATPase; TMR, tetramethylrhodamine; VSMC, vascular smooth muscle cell; WGA, wheatgerm agglutinin
1To whom any correspondence should be addressed (email F.Michelangeli@bham.ac.uk).
signalling has also been noted in human VSMCs from diabetic
patients [4].
Abnormal expression and/or activity of specific proteins that
participate in Ca2+ signalling and homoeostasis have been linked
to diabetes. These include Ca2+-dependent enzymes, such as in-
creased activity of both calpain in rat endothelial cells [5] and
CaMKII (Ca2+/calmodulin-dependent protein kinase II) in rat
whole carotid arteries [6]. In addition, it has been shown that Ca2+
transporters can be influenced by the diabetic state in vascular
cells. Examples of these include the inhibition of store-operated
Ca2+ channels in rat microvascular smooth-muscle cells [7] and
increased activity of T-type Ca2+ channels in rat cardiomyocytes
www.bioscirep.org / Volume 29 (6) / Pages 397–404 397
B
io
sc
ie
nc
e 
Re
po
rts
   
  	w
w
w
.b
io
sc
ire
p.
or
g
© 2009 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
P. Lai and F. Michelangeli
[8]. The SERCA (sarcoplasmic/endoplasmic reticulum Ca2+-
ATPase) has also been shown to differ between healthy and dia-
betic subjects, both in the form of decreased expression levels in
heart from streptozotocin-induced diabetic rats [9] and increased
activity in rat primary VSMCs cultured in high-glucose medium
[10].
The SPCA1 (secretory pathway Ca2+-ATPase 1; also known
as ATP2C1), a Golgi-apparatus-localized Ca2+ ion pump that is
relatively highly expressed in VSMCs [11], has not been invest-
igated in relation to diabetes-related cardiovascular pathology.
It is unlikely, however, that the other isoform, SPCA2, plays a
substantial role in cardiovascular pathology, since it is not sig-
nificantly expressed in vascular tissue [12]. However, previous
studies have linked SPCA1 expression to diabetes in pancreatic
cells [13]. Furthermore, alterations in the Golgi apparatus have
also been observed in VSMCs treated with kinase inhibitors to
inhibit proliferation [14]. SPCA1 is important for establishing a
store of Ca2+ ions in the Golgi apparatus, which is required by
Ca2+-dependent enzymes essential for post-translational modi-
fication of proteins in transit through the secretory pathway [15].
In the present study, we utilize one of the most commonly em-
ployed cell lines for VSMCs (A7r5 cells) to determine whether
culturing them in either NG [glucose (5.55 mM) culture medium]
or HG [high glucose (25 mM) culture medium], to mimic the
‘normal’ and ‘hyperglycaemic’ glucose homoeostatic states, spe-
cifically alters the expression and activity of SPCA1.
MATERIALS AND METHODS
A7r5 cell culture and treatment
A7r5 (rat embryonic thoracic aortic smooth muscle) cells [a gift
from Professor C.W. Taylor (University of Cambridge, Cam-
bridge, U.K.)] were cultured in DMEM (Dulbecco’s modified
Eagle’s medium; Lonza), which was supplemented with 10 %
FBS (foetal bovine serum), 4 mM L-glutamine, 1 % non-essential
amino acids and 1 % 1:1 penicillin/streptomycin (PAA Laborat-
ories). Growth was maintained under conditions of 37◦C and 5 %
CO2. Culture medium contained 25 mM D-glucose when cells
were maintained for growth or for obtaining cells in the ‘hyper-
glycaemic’ HG-cultured state. Subculturing of cells was done
every 3–4 days by trypsinization using 0.05 % trypsin/EDTA
solution (Invitrogen). Cells in the NG-cultured state were ini-
tially obtained by seeding a new flask of subcultured cells from
HG medium into NG (5.55 mM D-glucose) medium. Both NG
and HG cells were subcultured for at least a further two passages
in their respective medium before being used for experimenta-
tion.
PCR
mRNA was extracted from cells and converted into cDNA cop-
ies via RT–PCR (reverse transcription–PCR), using a Super-
script III CellsDirectTM cDNA synthesis kit (Invitrogen). Cells
were harvested by trypsinization, washed with cell culture PBS
(phosphate-buffered saline) and resuspended in 0.1 % (v/v) DEPC
(diethyl pyrocarbonate)-treated PBS. To prepare each cDNA
sample, 2 × 104 cells were used.
BIOTAQTM Taq DNA polymerase and dNTP mixture were
purchased from Bioline. All the primers were made by Alta Bios-
cience (University of Birmingham, Birmingham, U.K.). Primer
sequences and their specific PCR conditions were obtained from
the following associated references: SPCA1 [16], SERCA [17],
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [18], β-
actin [17] and RPL19 (ribosomal protein L19) [19]. The SPCA1
primers only recognized mRNA corresponding to the SPCA1 iso-
form (all splice variants). The SERCA primers recognized mRNA
corresponding to all SERCA isoforms. Each 50 μl PCR reac-
tion mixture contained 2.5 units of BIOTAQTM, 2 mM dNTP mix
and 1 μl of cDNA sample. SPCA1 and SERCA PCRs required
35 cycles. GAPDH, β-actin and RPL19 required 28 cycles. All
PCR products were separated by agarose-gel electrophoresis,
stained with SYBR® Safe DNA gel stain (Invitrogen) and visu-
alized using a UV transluminator. PCR product band sizes were
checked using a 100 bp DNA ladder (New England Biolabs).
Images of stained gels were taken using an UVP ImageStore
5000 system. Analysis was undertaken using ImageJ (version
1.41e; National Institutes of Health). Mean pixel intensity values
were measured for the product bands, each of which was cor-
rected for background and made relative to those for RPL19 (a
commonly used internal control for PCRs [19]) from the same
sample to correct for differences in total cDNA quantity. The
expression of RPL19, a housekeeping protein, was unlikely to
be affected by different glucose culture conditions in A7r5 cells
when compared with other control markers, such as GAPDH (a
glycolytic enzyme) and β-actin (a contractility marker [20]). Val-
ues for HG samples were made relative to their counterpart NG
samples.
SDS/PAGE and Western blotting
Cell lysate samples were prepared using a proportion of the
same cells used for cDNA preparation. For each sample,
(1–1.25) × 106 cells were incubated on ice for 2 h in lysis buf-
fer (50 mM Tris/HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 %
Triton X-100, 1 % sodium deoxycholate, 0.1 % SDS and 1 mM
PMSF). The cell suspension was then homogenized by passing
it through a 21-gauge needle via a syringe; it was centrifuged at
2400 g for 5 min, and the supernatant was collected.
Proteins in all cell lysate samples were separated by
SDS/PAGE, transferred on to nitrocellulose sheets by Western
blotting and probed with antibodies for SPCA1, SERCA and
α-actin. The methodology was the same as described previously
in [11] with the following modifications: 20 μg of protein was
loaded for each sample for SDS/PAGE; anti-SPCA1 (custom an-
tibody from BioCarta; [11]), anti-SERCA (YIF4) (a gift from
Dr J.M. East, Southampton University, Southampton, U.K.) and
anti-α-actin (clone 1A4; Sigma) antibodies were diluted in TTBS
(Tween/Tris-buffered saline) at ratios of 1:75, 1:800 and 1:800
respectively and incubated with the blots for 90 min; after incub-
ation with HRP (horseradish peroxidase)-conjugated secondary
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Glucose increases expression of SPCA1 in VSMCs
antibodies (1:3000 dilution), ImmobilonTM Western chemilumin-
escent HRP substrate (Millipore) was used to visualize antibody-
bound protein bands; HRP-substrate-treated blots were viewed
and images were captured using a Bio-Rad Fluor-S Max MultiIm-
ager. Images were analysed with ImageJ software to determine
pixel intensity values for each product band. These were correc-
ted for background and values for the HG samples were made
relative to their counterpart NG samples.
Microsomal membrane preparation
The method used was as previously described [11] with the fol-
lowing modifications: cells were harvested by trypsinization,
washed with PBS and centrifuged at 900 g for 10 min at 4◦C;
the pellet was homogenized with both Polytron and Potter–
Elvehjem-type homogenizers after resuspension in membrane
preparation buffer; the homogenate was centrifuged at 20 000 g
for 15 min at 4◦C, the pellet was re-homogenized and cent-
rifuged again, and the two supernatants were combined and
centrifuged at 100 000 g for 50 min at 4◦C. The final pellet, which
contained the microsomal membranes, was resuspended in fresh
buffer, divided into aliquots, snap-frozen in liquid nitrogen and
stored at –80◦C.
Ca2+-dependent ATPase activity
Ca2+ dependent ATPase activity was measured using the phos-
phate liberation method, as previously described [21], with minor
modifications. The assay buffer included sodium azide (2 mM)
and vanadate (2 μM) to inhibit mitochondrial Ca2+ uptake and
PMCA (plasma-membrane Ca2+-ATPase) respectively. The re-
action period was 90 min and each reaction mixture contained
20 μg of microsomal membrane proteins. In order to distinguish
between Ca2+-ATPase activity from SERCA and SPCA, experi-
ments were repeated in the presence and absence of 1 μM thap-
sigargin (Sigma) as this would completely inhibit SERCA and
have minimal effects on SPCA activity [21,22].
Intracellular Ca2+ imaging
The method used was the same as described previously in [23],
but with minor modifications. The cells were grown at a dens-
ity of 1 × 104 cells per coverslip and loaded with Fluo-3/AM
(acetoxymethyl ester) (Sigma) at a final concentration of 6 μM
in HBSS (Hanks balanced salt solution). After 45 min of incuba-
tion, the cells were incubated in HBSS containing sulfinpyrazone
(200 μM) for 10 min. Fluo-3-loaded cells were then viewed us-
ing an inverted epifluorescence microscope (Nikon TS-100F)
with filters specifically designed to monitor Fluo-3 fluorescence
and a × 10 objective. The video images were recorded using a
StellaCam Astrovid3 camera connected to a computer using
a Hauppage USB TV live video-capture device and soft-
ware (set at 1 frame/s). After initiation of the recordings,
the cells were treated with 1 μM thapsigargin for 5 min prior
to the addition of 10 nM AVP (arginine-vasopressin; Bachem
Biosciences). After the latter treatment, recordings were collec-
ted for a further 5 min.
Changes in Fluo-3 fluorescence intensity induced by AVP were
measured using ImageJ software, and corrected for both back-
ground and photobleaching as previously described [23]. Values
for each cell were made relative to their basal fluorescence in-
tensity value at the time point of AVP application. These relative
values were used to produce Ca2+ transient plots, from which the
kinetics of the rise and decay phases could be calculated.
Immunohistochemistry and lectin staining
The method used was the same as described previously in
[11], but with the following modifications: cells were seeded
at a density of (3–4.5) × 104 cells per coverslip; prior to an-
tibody treatment, they were fixed with 2 % (v/v) formalde-
hyde in PBS; anti-SPCA1 and anti-SERCA working dilutions
were 1:30 and 1:100 respectively; TMR (tetramethylrhodamine)-
conjugated WGA (wheat-germ agglutinin; Invitrogen) (for Golgi
apparatus labelling) was used at 10 μg/ml per coverslip. The la-
belled cells were viewed using fluorescence microscopy, with
appropriate filters. Digital photographs of the cells were collec-
ted using the same imaging system as described above, except
that the images were recorded at a 640 × 480 pixel resolution.
Statistical analysis
S.E.M. were calculated for results from PCRs, Western blots,
Ca2+-ATPase assays and kinetic measurements from Fluo-3
fluorescence Ca2+ imaging experiments. A two-tailed equal vari-
ance Student’s t test and ANOVA (Minitab) were used to test for
statistical significance (P).
RESULTS
Figure 1 shows the PCR products, which relate to mRNA expres-
sion levels, for SPCA1, SERCA, GAPDH and β-actin. The res-
ults were obtained from triplicate paired cultures, where the PCR
products of the transcripts in HG-cultured cells were compared
with their corresponding paired NG-cultured cells and then ex-
pressed as a percentage. The results showed that the relative
expression of SPCA1 and SERCA, in HG-cultured cells com-
pared with NG-cultured cells, were found to have increased by
60 +− 13 % and 19 +− 5 % respectively. Furthermore, these changes
in expression were statistically significant between the two condi-
tions (i.e. P< 0.01 for SPCA1 and P< 0.05 for SERCA). In con-
trast, the mRNA expression levels for GAPDH and β-actin were
not substantially affected (i.e. 7 +− 4 % and −4 +− 3 %, for GAPDH
and β-actin respectively). Figure 1 also shows representative gels
of the PCR products for the different mRNA transcripts isolated
from cells grown in HG- and NG-cultured media.
Figure 2 shows the mean differences in protein levels determ-
ined using total cell lysate samples from triplicate paired cultures
and expressed as a percentage of the HG cells compared with
NG cells. The results confirmed the PCR study by showing that
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Figure 1 Differences in mRNA content for SPCA1, SERCA, GAPDH
and β-actin in hyperglycaemic compared with normal glucose-
cultured A7r5 cells
PCRs were repeated in triplicate using samples from three replicate cell
cultures for each primer pair and glucose culture condition. A final mean
relative band intensity value was calculated from the three PCR replic-
ates for each primer pair and glucose culture condition. Band intensity
values from each sample were corrected for background and made re-
lative to RPL19 values from matching samples. Relative percentage
changes were calculated from values obtained from HG relative to NG
cells (HG/NG). Error bars represent S.E.M. values. Statistically signific-
ant P-values are indicated by * (for P values<0.05) and ** (for P values
<0.01). The images under each bar show the associated typical PCR
product band intensities observed for each of the primer pairs, whereby
HG and NG represent the proteins derived from cells grown under
hyperglycaemic and NG culture conditions respectively. The PCR product
band sizes for each mRNA of interest were, from left to right, 224 bp
(SPCA1), 288 bp (SERCA), 400 bp (GAPDH) and 255 bp (β-actin).
HG-cultured cells had an increased abundance of SPCA1 (by
15 +− 5 %), as well as a small or negligible change in SERCA
(by 9 +− 4 %) and α-actin (by 2 +− 4 %) protein when compared
with NG-cultured cells. The increase in SPCA1 protein levels
between HG- and NG-cultured cells was found to be statistically
significant (P< 0.05). Figure 2 also shows representative West-
ern blots for SPCA1, SERCA and α-actin protein levels detected
in samples from NG- and HG-cultured A7r5 cells.
To determine whether increased SPCA1 expression resulted
in increased SPCA-specific Ca2+-ATPase activity, microsomal
membranes were isolated from HG- and NG-cultured cells,
and measured using the phosphate liberation assay (Table 1).
Thapsigargin (1 μM) was used to distinguish the contribu-
tions made by SERCA and SPCA. The assay buffer also con-
Figure 2 Differences in protein content for SPCA1, SERCA and
α-actin in hyperglycaemic compared with normal glucose-
cultured A7r5 cells
Western blots were repeated twice for each of three replicate cell cul-
tures for each primary antibody and glucose culture condition. These
were then used to calculate a final mean relative band intensity value
for each protein of interest, and percentage changes in these proteins
for HG cells relative to NG cells were calculated. Error bars represent
the S.E.M. of the differences. Statistically significant P values (where
P<0.05) are indicated by *. The images under each bar show the as-
sociated typical protein band intensities observed for each of the target
proteins, whereby HG and NG represent the proteins derived from cells
grown under hyperglycaemic and NG culture conditions respectively. The
molecular mass for each protein was, from left to right, ∼100 kDa for
both SPCA1 and SERCA and 42 kDa for α-actin.
tained both 2 mM azide and 2 μM vanadate to inhibit the mi-
tochondrial Ca2+ uptake/activity and plasma membrane Ca2+-
ATPase activity respectively. Under these experimental condi-
tions, the Ca2+-dependent ATPase activities were deemed to
be predominantly due to either a combination of SERCA and
SPCA (in the absence of thapsigargin) or SPCA alone (in the
presence of thapsigargin) [20]. Due to the inherent variabil-
ity in Ca2+-ATPase activities from different membrane prepar-
ations, experiments were done using samples of microsomal
membranes isolated from three replicate pairs of HG and NG
cell cultures. Table 1 shows that the Ca2+-ATPase activities
from the three membrane preparations, isolated from NG- and
HG-cultured cells, were similar in the absence of thapsigargin.
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Table 1 Ca2+-dependent ATPase activities of microsomal membranes from normal glucose and hyperglycaemic
cultured A7r5 cells
Ca2+-dependent ATPase activity (nmol/min per mg of protein)(mean+−S.E.M.)
Absence of thapsigargin 1 μM Thapsigargin
Membrane preparation NG HG NG HG
1 3.2 +− 0.5 3.1 +− 0.7 0.62 +− 0.09 1.05 +− 0.17
2 4.1 +− 1.6 2.7 +− 0.4 0.38 +− 0.07 2.89 +− 1.21
3 4.4 +− 0.5 3.7 +− 0.2 1.26 +− 1.17 1.63 +− 0.48
(The mean activities were 3.9 +− 0.5 and 3.2 +− 0.4 nmol/min
per mg of protein for NG- and HG-cultured cells respectively).
On the other hand, in the presence of 1 μM thapsigargin, the
Ca2+-ATPase activities did show significant differences between
the membranes isolated from NG- and HG-cultured cells, with
higher activities consistently obtained from HG-cultured cell
membranes. Mean activities for the three membrane prepara-
tions were 0.75 +− 0.27 nmol/min per mg of protein for NG cells
and 1.86 +− 0.55 nmol/min per mg of protein for HG
cells. Statistical analysis showed that the activity differences
between the two culture conditions were significant (P< 0.05).
A comparison of total Ca2+-ATPase activity (from SERCA
and SPCA) in the membranes, with the activity for SPCA alone,
showed that SPCA accounted for between 20 and 60 % of the
Ca2+-ATPase activity in A7r5 cultured cells. This is not dissimilar
from our previous findings in aortic VSMC membranes, where we
showed that approx. 50 % of total ATP-dependent Ca2+ uptake
into these membranes was due to SPCA [11]. Therefore these
findings again strongly suggest that SPCA plays a significant
role in Ca2+ uptake into Ca2+ stores within VSMCs.
To assess whether increased expression of SPCA1 can alter the
profile of agonist-induced cytosolic [Ca2+] transients, NG- and
HG-cultured cells, loaded with Fluo-3, were treated with 10 nM
AVP. These cells were first pre-treated with 1 μM thapsigargin
in order to minimize the effects of SERCA on their response to
AVP. Figure 3 shows the averaged traces (with each trace com-
prising results from ten individual cells) of Fluo-3 fluorescence
change in both NG (Figure 3A) and HG (Figure 3B) cells. Al-
though the peak values in AVP-induced Ca2+ transients were
similar in cells from the two glucose culture conditions, their
kinetic profiles were notably different. The Ca2+ transients ob-
served for NG-cultured cells were much longer than those for
HG-cultured cells, for both the rise and the decay phases of the
transients. However, if the cells were not initially pre-treated
with thapsigargin, the kinetics of the Ca2+ transients for both
NG- and HG-cultured cells were very similar to each other and
shorter (insets), consistent with observations from previous stud-
ies [24]. The mean peak heights between cells not treated and
those pre-treated with thapsigargin, for both NG and HG culture
conditions, were each reduced by approx. 60 %. This shows that
the contribution made by SERCA-containing Ca2+ stores to the
AVP-mediated Ca2+ responses in these cells is not overwhelm-
ingly dominant and SPCA-containing Ca2+ stores are also likely
to contribute significantly.
Figure 3 Ca2+ transients induced by AVP after pre-treatment
with thapsigargin in hyperglycaemic and normal glucose-cultured
A7r5 cells
For both (A) NG and (B) HG culture conditions, the main Figures show
results from four coverslips, whereby each trace represents averaged
fluorescence values from ten cells, analysed for Fluo-3 fluorescence
changes (F/F0) in response to 10 nM AVP, after pre-treatment of cells
with thapsigargin. The insets show the typical response profile (aver-
aged from ten cells) for 10 nM AVP after pre-treatment with DMSO
(vehicle control for thapsigargin) in cells from the same glucose culture
conditions. Arrows indicate when AVP was added.
The kinetic measurements taken from the Ca2+ transient traces
representing post-thapsigargin AVP responses showed a quant-
itative difference between cells cultured in NG and HG media
(Table 2). The mean time taken to increase from basal to peak
[Ca2+]i levels of the AVP response was approx. 3-fold longer in
NG-cultured cells compared with HG-cultured cells. The half-life
for the decay in [Ca2+]i from the peak back towards basal levels
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Table 2 Kinetics measurements from AVP-mediated Ca2+
responses in normal glucose and hyperglycaemic cultured A7r5
cells, after pre-treatment with thapsigargin
Value
Measurement NG HG
Time taken to reach
half-maximal response (s)
48.3 +− 5.1 18.2 +− 3.2
Half-life of decay in
response (s)
76.9 +− 7.4 39.7 +− 5.7
Figure 4 Immunolocalization of SPCA1, Golgi apparatus and
SERCA in A7r5 cells
Immunostaining for SPCA1 using the anti-SPCA1 antibody (1:30 dilu-
tion) in (A) NG- and (B) HG-cultured cells. NG cultured cells were used to
identify the location of the Golgi apparatus with TMR–WGA (10 μg/ml)
(C) and the Y1F4 antibody (1:100 dilution) for SERCA (D). Cells were
viewed at × 200 magnification under epifluorescence microscope.
was also approx. 2-fold lower in NG cells. Statistical analysis of
these kinetic measurements for both HG- and NG-cultured cells
showed that these differences were significant (i.e. P< 0.05, for
both the rise and decay phases comparing NG- and HG-cultured
cells).
Immunolocalization of SPCA1, together with WGA-based
lectin affinity staining, in NG- and HG-cultured cells showed that
SPCA1 and the Golgi apparatus share a very similar distribution
pattern, based on its characteristic perinuclear staining (Figure 4).
WGA binding is commonly used as a marker for the Golgi ap-
paratu because it binds to glycoproteins highly abundant in this
organelle [25]. Comparison of the staining patterns for SPCA1
showed no notable differences between NG- and HG-cultured
cells. Thus localization of SPCA1 in A7r5 cells was largely un-
affected by the glucose culturing conditions. Immunostaining for
SERCA showed a more uniform distribution throughout the cell
that was distinct from those observed for both SPCA1 and WGA
and which we have previously reported elsewhere for primary
VSMCs [11].
DISCUSSION
Results obtained by Wootton et al. [11] showed rat aortic tissue
and primary human aortic VSMCs express relatively high levels
of SPCA1 protein compared with many other tissues and cell
types. From Ca2+-dependent ATPase measurements we show
that between 20 and 60 % of the Ca2+-ATPase activity associated
with intracellular membranes of A7r5 cells is derived from SPCA.
Again this is similar to our previous findings, which showed that
in aortic VSMC membranes approx. 50 % of the ATP-dependent
Ca2+ uptake is via SPCA [11]. This is also corroborated by the
fact that substantial increases in AVP-induced intracellular [Ca2+]
were observed in thapsigargin-pre-treated cells, which suggests
that these VSMCs must contain a sizeable SERCA-independent
mobilizable Ca2+ store. Therefore, taken together, these findings
highlight the substantial role SPCA plays in Ca2+ store refilling
within VSMCs.
It has also been well established that vascular tissues prone
to developing atherosclerotic plaques (as observed in diabetes
mellitus [26]) have a tendency to change their VSMCs from a
contractile to a secretory phenotype [27]. This is characterized by
their increased ability to produce secreted proteins, such as col-
lagen and proteoglycans found in the extracellular matrix [28].
Since SPCA1 plays an important role in both post-translational
modification of proteins in the Golgi apparatus and transit of pro-
teins through the secretory pathway, the aim of the present study
was to investigate whether SPCA1 expression and/or activity is
different between NG and HG-cultured A7r5 cells, a commonly
used cell line for VSMCs.
Measurements of mRNA and protein levels in this study
showed A7r5 cells grown in HG culture medium expressed meas-
urably more SPCA1 than cells grown in NG culture medium,
which suggests that glucose availability can influence the expres-
sion of this protein. There was a notable difference, however,
in the extent of change between SPCA1 mRNA and protein ex-
pression levels, whereby a 60 % increase in mRNA resulted in
only approx. 15 % increase in protein. A similar discrepancy was
observed by Reinhardt et al. [29] when they compared SPCA
expression levels between rat mammary and brain tissue, and
attributed their finding to a difference in protein turnover. A sim-
ilar explanation may, at least in part, explain our observation
in A7r5 cells. Transcriptional control of SPCA1 may also play
a role, since Sp1 and YY1, which are the transcription factors
of the SPCA1 gene [30], possess increased activity in cells
grown in high, compared with normal, glucose media [31,32].
One possibility could be that a combination of enhanced tran-
scription and near-maximal translation of the SPCA1 gene in
hyperglycaemic A7r5 cells may result in an increase in its mRNA,
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Glucose increases expression of SPCA1 in VSMCs
but not necessarily increase in its protein levels to the same
extent.
Consistent with results from PCR-based mRNA measurement
and immunochemical detection of SPCA1 protein, thapsigargin-
insensitive Ca2+-dependent ATPase activity in microsomal mem-
branes (representative of SPCA activity) was also found to be
higher from HG, compared with NG, cultured cells. However,
the mean activity for the HG-cultured cells was approx. 2-fold
higher than that for the NG-cultured cells, which would
also appear to be disproportionate to the increase in SPCA1
protein levels observed. Such differences may be explained by
the differences in Ca2+ transport activities between different
SPCA1 splice variants [33]. In our present study, we measured
all SPCA activity and the expression of all SPCA1 slice vari-
ants. However, one could envisage that an increased expression
of SPCA1 splice variants that have higher levels of activity could
contribute to the higher than normal SPCA activity observed in
HG-cultured cells. However, this possibility needs to be further
explored.
In order to assess whether higher than normal expression of
SPCA1 within HG-cultured A7r5 cells can alter agonist-induced
cytosolic [Ca2+] transients, the effects of AVP on cytosolic [Ca2+]
profiles were investigated. AVP (working through the phospho-
inositide pathway) initiates Ca2+ mobilization from internal Ca2+
stores and stimulates Ca2+ entry from the extracellular medium.
Cytosolic Ca2+ removal (by uptake into intracellular stores and
extrusion out of the cell) then follows, resulting in a typical Ca2+
transient profile [24]. In our present study, using thapsigargin-
pre-treated A7r5 cells, we showed that, although the peak heights
of SERCA-independent AVP-induced Ca2+ transients were not
significantly different between NG- and HG-cultured cells, these
transients were different with regard to both their rise and de-
cay phase kinetics. The differences in the rise and decay phase
kinetics could be attributed to differences in the abundance of
thapsigargin-insensitive IP3-releasable Ca2+ stores (i.e. Golgi
Ca2+ stores). Thus, if HG-cultured cells had more of these Ca2+
stores than NG-cultured cells, this could result in higher rates
of Ca2+ release, as well as higher rates of Ca2+ re-uptake (due
to their higher levels of SPCA). This becomes even more appar-
ent once SERCA-containing Ca2+ stores have been emptied by
thapsigargin treatment.
Our immunostaining studies confirm that SPCA1 remains loc-
ated at the distinct regions within the cell consistent with being the
Golgi apparatus, rather than more widely distributed throughout
the endoplasmic reticulum like SERCA. Furthermore, increased
SPCA expression, as observed in HG-cultured cells, does not
appear to affect its subcellular location (Figure 4).
In summary, the present study has shown that culturing A7r5
cells (a commonly used VSMC model) in HG medium (which
mimics the hyperglycaemic state associated with severe diabetes
mellitus) can lead to: (i) higher SPCA1 expression levels (both
at the mRNA and protein levels); (ii) increased thapsigargin-
insensitive Ca2+-ATPase activity, which is comparable with the
activity observed for SERCA; and (iii) higher rates of both
the rise and decay phases of AVP-induced Ca2+ transients in
thapsigargin-pre-treated cells. These findings suggest that gluc-
ose availability can substantially affect the Ca2+-handling proper-
ties within the Golgi apparatus and therefore affect the secretory
pathway and post-translational protein modification processes,
as well as Ca2+-mediated hormonal responses, in A7r5 VSMCs.
If these changes in SPCA1 expression and activity also occur in
primary VSMCs, this might potentially contribute towards car-
diovascular diseases often associated with diabetes. Therefore
further studies are required, using primary VSMCs cultured in
different glucose media, as well as studying cells isolated from
normal and severely diabetic animals, in order to corroborate this
hypothesis.
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